Medical experts have warned that Nigeria is at risk of yearly, multiple, and concurrent disease outbreaks due to tropical climate, population density and poor socio-economic factors. They, however, said the country is yet to see the worst of the COVID-19 pandemic.
The medical experts brainstormed on lessons from the COVID-19 pandemic and other disease outbreaks at the maiden edition of the Nigerian Conference of Applied and Field Epidemiology (NiCAFE). The conference, which was held virtually, was organised by the Nigeria Centre for Disease Control (NCDC) in collaboration with partners from July 26 to 28, 2021. x
The theme of this year’s NiCAFE conference was “Building back better: COVID-19 and other disease outbreaks”.
Africa CDC raises alarm over continent s infectious diseases outbreaks premiumtimesng.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from premiumtimesng.com Daily Mail and Mail on Sunday newspapers.
Vaccine inequity: Inside the cutthroat race to secure doses By Associated Press International
SHARE
No one disputes that the world is unfair. But no one expected a vaccine gap between the global rich and poor that was this bad, this far into the pandemic.
What You Need To Know
As the U.S. struggles to curb vaccine skepticism in some parts of the country– offering incentives such as lottery tickets, concert passes, and gift cards to encourage participation, other nations are struggling to procure enough shots for their most vulnerable residents
The disparity in inoculation rates has put on stark display the vaccine inequity that counties to separate the global rich and poor
Vaccine inequity: Inside the cutthroat race to secure doses japantoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from japantoday.com Daily Mail and Mail on Sunday newspapers.
CEPI and IVI announce new research program to expand access to COVID-19 vaccines in Africa
The Coalition for Epidemic Preparedness Innovations (CEPI) and the International Vaccine Institute (IVI) today announced a new programme of clinical research which aims to expand access to COVID-19 vaccines in Africa. CEPI will provide funding of up to $12.7m to the Expanding Access and Delivery of COVID-19 Vaccines in Africa (ECOVA) consortium led by IVI to carry out clinical trials of Sinopharm s BBIBP-CorV vaccine which will support the expanded use of the vaccine on the African continent.
Up to 170 million doses of BBIBP-CorV will be distributed by the COVAX Facility under an agreement announced on 12 July 2021, and the vaccine is already being deployed in over 50 countries around the world. However there have been no clinical trials of BBIBP-CorV in African populations or against the variants of concern circulating in southern Africa. The ECOVA research programme aims to generate crucial